You Searched For "mrna" and got 20 results
Sort By:
Six African countries to receive mRNA vaccine technology
But Ramaphosa repeated his call for lifting patent protections on coronavirus vaccines that he beli…
A 40-year-old woman had heart palpitations and thought it was because she worked out too hard. She was diagnosed with stage 4 pancreatic cancer.
Lindsay Gavin, 40, went to the hospital for heart palpitations. She was diagnosed with stage 4 panc…
Julia Pugachevsky
Finally, a vaccine for one of the deadliest forms of cancer
A new pancreatic cancer vaccine shows promise. In a small trial, treatment worked by using individu…
Julia Pugachevsky
Experts rate 12 vaccine claims by Robert Malone, the doctor catapulted to fame on Joe Rogan's podcast
Malone developed some of the first mRNA vaccines for mice in the 1980s. But experts say some of his…
Hilary Brueck,Andrew Dunn
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
Experts allay fears: It is Covid that triggers heart attacks, not vaccines
There has been a rising spate of heart attacks in India, particularly post Covid-19 pandemic. While…
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
COVID: China is developing its own mRNA vaccine – and it's showing early promise
The mRNA vaccines initially generated high levels of protection against getting COVID. And while th…
PTI
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
Here are the top 10 most-traded stocks among retail investors this year, according to Nasdaq
Meme stocks like AMC made the list along with exchange-traded funds, according to Nasdaq's Retail T…
Natasha Dailey
China is still racing to develop its own mRNA jabs. But they won't use foreign vaccines to fight COVID because of 'national pride,' says South Korea's top vaccine maker.
After three years of zero-COVID policy, Beijing abruptly rolled back the policy in December, which …
Huileng Tan
Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety
The decline comes with Moderna's stock having surged 693% year-to-date through Monday's close.
Ben Winck
Researchers are now working on an oral Covid-19 vaccine that people can 'drink'
Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a nee…
India to face 'tsunami' of chronic diseases like cancer: US-based oncologist
India will face a tsunami of chronic diseases such as cancer due to globalization, a growing econom…
PTI
Fauci says US still planning for COVID-19 booster after 8 months. Biden said shots could be administered after 5.
Fauci said he was "certain" mRNA vaccines would need a third dose and said officials first recommen…
Connor Perrett
Moderna climbs 12% after saying its coronavirus vaccine likely protects against new strains found in the UK and South Africa
Moderna stock jumped after the biotech company said its COVID-19 vaccine can likely protect against…
Emily Graffeo
Retail purchases of Moderna and Pfizer stock hit an 8-month high as Delta infections accelerate
Individual investors have bought a combined $180 million of stock in the COVID vaccine makers in re…
Carla Mozée
The rise of Robert Malone, the mRNA scientist turned vaccine skeptic who shot to fame on Joe Rogan's podcast
Robert Malone has become a favorite source of information for people who aren't sure about the safe…
Hilary Brueck
Moderna sinks 6% as investors continue to secure profits from massive vaccine rally
Moderna is awaiting FDA authorization after a panel of experts recommended the vaccine be approved …
Emily Graffeo
India's first homegrown mRNA COVID-19 vaccine currently under final clinical trial stages: Govt
"Having an India vaccine platform is an asset in the wake of COVID-19 and Omicron, but also for ot…